Unlock instant, AI-driven research and patent intelligence for your innovation.

N-(-1-hydrogen-inden-1-yl)sulfonamide compounds and their preparation methods and uses

A compound, C1-C12 technology, applied in the field of medicine to achieve the effect of avoiding poor selectivity, strong targeting, and good therapeutic potential

Inactive Publication Date: 2015-11-25
HUBEI BIO PHARMA IND TECHCAL INST
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At the same time, due to the shortcomings of the anti-platelet drugs currently on the market, there are very few drugs with good curative effect, high safety and convenient administration. Therefore, the successful development of new anti-platelet drugs has huge social value and economic benefits.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • N-(-1-hydrogen-inden-1-yl)sulfonamide compounds and their preparation methods and uses
  • N-(-1-hydrogen-inden-1-yl)sulfonamide compounds and their preparation methods and uses
  • N-(-1-hydrogen-inden-1-yl)sulfonamide compounds and their preparation methods and uses

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0142] Example 1: 2-(1-(4-fluorobenzenesulfonamido)-1-hydrogen-inden-4-yl)acetic acid (A001) (prepared according to Reaction Scheme 1)

[0143] 1.1 Preparation of 3-(2-(bromomethyl)phenyl)methyl acrylate

[0144] Add 2.97g of iodobenzyl bromide, 1.72g of methyl acrylate, 225mg of palladium acetate, 2.78g of tetrabutylammonium chloride, 4.14g of potassium carbonate and 50mL of anhydrous DMF into a 250mL reaction flask, nitrogen replacement 3 times, and stir at room temperature overnight. The reaction solution was poured into water, extracted 3 times with ethyl acetate, combined the organic phases, washed 2 times with 0.1N HCl and 2 times with saturated brine, dried, filtered, spin-dried the solvent, and purified by column chromatography to obtain 2.1 g of Yellow oil.

[0145] 1 HNMR (CDCl 3 ,400MHz):δ8.07(d,J=16.0Hz,1H),7.67-7.56(m,1H),7.42-7.31(m,3H),6.45(d,J=16.0Hz,1H),4.60( s,2H),3.84(s,3H).ESI-MSm / z:256[M+H] + .

[0146] 1. Preparation of 24-bromomethyl-1-hydrogen-1-...

Embodiment 2

[0158] Example 2: 2-(1-(4-fluorobenzenesulfonamido)-1-hydrogen-inden-4-yl)-3-oxobutanoic acid (A015) (prepared according to the reaction scheme 2)

[0159] Dissolve 3.6g of compound A001 in THF, add EDCI to react for 2 hours, then add 1.1 equivalent of methyl malonate monopotassium salt, after reacting for 10 hours, add 2N NaOH aqueous solution, after reacting at room temperature for 2 hours, the reaction solution Adjusted to neutral, extracted with ethyl acetate, washed with saturated brine, dried, spin-dried, and purified by column chromatography to obtain an off-white solid.

[0160] 1 HNMR(d 6 -DMSO,400MHz):δ12.34(br,1H),7.96-7.87(m,2H),7.42-7.10(m,6H),6.53(d,J=2.4Hz,1H),6.33(d,J =2.4Hz,1H),4.69(s,2H),3.45-3.37(m,4H).ESI-MSm / z:412[M+Na] + .

Embodiment 3

[0161] Example 3: 2-(2-(1-(4-fluorobenzenesulfonyl)-hydrogen-inden-4-yl)acetamido)acetic acid (A029) (prepared according to Reaction Scheme 3)

[0162] 3.1 Preparation of ethyl 2-(2-(1-(4-fluorobenzenesulfonyl)-hydrogen-inden-4-yl)acetamido)acetate

[0163] Add 3.6g of compound A001, 1.37g of glycine methyl ester hydrochloride, 1.1 equivalents of TBTU, 1.1 equivalents of triethylamine and 40mL of DCM into the reaction flask, react at room temperature for 2 hours, wash 3 times with 0.1N HCl, and wash 2 times with saturated saline , dried, filtered, and spin-dried to obtain a crude product. used directly in the next step.

[0164] ESI-MSm / z:455[M+Na] + .

[0165] 3.2 Preparation of 2-(2-(1-(4-fluorobenzenesulfonyl)-hydrogen-inden-4-yl)acetamido)acetic acid

[0166] The product from the previous step was dissolved in 40 mL THF, 40 mL 2N NaOH aqueous solution was added, and vigorously stirred for 2 hours. The reaction solution was adjusted to neutrality, extracted, dried, and...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention proposes a compound, which is N-(-1-hydrogen-inden-1-yl)sulfonamide compound shown in formula I or its enantiomer, diastereoisomer, racemate Rotary body, pharmaceutically acceptable salt, crystalline hydrate or solvate. The compound can be used to prepare medicines for treating or preventing diseases related to thromboxane receptors, or for treating or preventing thrombosis and / or hypertension.

Description

technical field [0001] The present invention relates to the field of medicine, specifically, the present invention relates to N-(-1-hydrogen-inden-1-yl)sulfonamide compounds and their preparation methods and applications. More specifically, the present invention relates to a class of N-(-1-hydrogen-inden-1-yl)sulfonamide compounds and their derivatives represented by general formula I with novel structure, their preparation methods, pharmaceutical compositions and their use in The preparation is used in the preparation of drugs for treating diseases related to thromboxane receptors, especially cardiovascular diseases such as thrombosis and hypertension. Background technique [0002] Cardiovascular disease is one of the most serious diseases threatening human beings in the world today. About 17 million people die from cardiovascular disease every year in the world, and its morbidity and mortality have surpassed tumor diseases and ranked first in the world. According to WHO s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C311/20C07C311/07C07C311/29C07C303/40C07D295/155C07D209/20A61K31/196A61K31/4965A61K31/195A61K31/405A61P7/02A61P9/12
Inventor 许勇乐洋郭涤亮李莉娥
Owner HUBEI BIO PHARMA IND TECHCAL INST